Elicio Therapeutics, Inc. SEC filings ELTX
Elicio Therapeutics, Inc. has 384 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Other events
|
Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2025 | May 19, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 24, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 30, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Jan 22, 2025 | Jan 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 21, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2024 | Aug 27, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 1, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Other events
|
May 24, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Other events
|
Apr 5, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Other events
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 22, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 20, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Other events
|
Sep 28, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Other events
|
Sep 7, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2023 | Aug 28, 2023 |
| 8-K/A | Amended current report | Aug 14, 2023 | May 31, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Other events
|
Jun 5, 2023 | Jun 3, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
Jun 2, 2023 | May 31, 2023 |
| 8-K |
Current report
Other events
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Other events
|
May 24, 2023 | May 23, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Other events
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 14, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jan 17, 2023 | Jan 13, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 22, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jul 25, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Results of operations
|
Jun 29, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Jan 4, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 26, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Agreement ended
|
Aug 30, 2021 | Aug 27, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Other events
|
Jun 29, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Results of operations
|
May 17, 2021 | May 17, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2021 | Mar 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2021 | Mar 8, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Feb 9, 2021 | Feb 4, 2021 |
Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1601485
- Former names
- Angion Biomedica Corp. (until May 30, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.